SCHEMBL15935694

SCHEMBL15935694

CCOCCSC(C)C(=O)c1ccc(C2CCCCC2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HAO1 Q9UJM8 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
HDAC1 Q13547 1/20 0.39
NOS3 P29474 2/20 0.38
NOS1 P29475 2/20 0.38
NOS2 P35228 2/20 0.38
MCHR1 Q99705 2/20 0.37
BCL2L1 Q07817 2/20 0.37
MCL1 Q07820 2/20 0.37
HDAC3 O15379 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
DEGS1 O15121 1/20 0.36
HPGD P15428 1/20 0.36
KIF11 P52732 1/20 0.36
RAPGEF3 O95398 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16790349 0.84 HAO1 (0.43) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL15935678 0.82 HAO1 (0.41) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL15935713 0.76 HAO1 (0.40) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL9667339 0.73 HDAC8 (0.54) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL13145950 0.72 HAO1 (0.51) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL27772232 0.72 HDAC8 (0.53) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL27928265 0.71 HAO1 (0.50) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL10458159 0.70 MMP2 (0.47) HAO1ALDH1A1MAPTSMN1; SMN2HDAC8
SCHEMBL17127361 0.70 NPY5R (0.41) ALDH1A1SMN1; SMN2
SCHEMBL17127332 0.70 SMN1; SMN2 (0.42) ALDH1A1MAPTSMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150331314-A1 PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2015-11-19 US disclosed
WO-2014119698-A1 PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150331314-A1 PATTERN FORMING METHOD, COMPOUND USED THEREIN, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION, RESIST FILM, MANUFACTURING METHOD OF ELECTRONIC DEVICE, AND ELECTRONIC DEVICE RER1, CROCC, RFT1 HAO1 2743/4885ALDH1A1 1334/4885MAPT 1525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.